EUVIMEDEUVIMED entdecken
Crossref

Clinical features and medical–surgical management overweight the inoculum effect and genotypic characteristics of MSSA in infective endocarditis

Thiziri Tala-Ighil iD, Guilhem Royer iD, Raphaël Lepeule, Vincent Fihman iD, Adrien Galy, Pascal Lim iD, Christophe Rodriguez, Hervé Jacquier iD, Paul-Louis Woerther iD

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Thiziri Tala-Ighil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France. Hauptthemen laut MEDLINE: Genotype, Endocarditis, Bacterial, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

MSSA remains the leading cause of infective endocarditis (IE) and is responsible for significant mortality. While clinical factors tied to mortality are well documented, possible contributing strain-specific characteristics have not been extensively explored. This study investigates MSSA phenotypic and genotypic characteristics and medical–surgical data related to Day-90 mortality in IE.

Methods

We included all patients enrolled in a monocentric prospective cohort (2016–23), with definite or probable MSSA IE. Cefazolin and oxacillin MICs and inoculum effects were determined by broth microdilution. Genotyping analysis and BlaZ typing were obtained from WGS. Phenotypic and genotypic characteristics of strains and clinical risk factors were confronted with Day-90 mortality.

Results

Eighty-eight patients with MSSA IE were included. The most frequent clinical presentations were left-sided native valve IE (25/88), left-sided prosthetic valve IE (12/88) and right-sided IE (19/88). Day-90 mortality rate was 39% (34/88). Most patients were treated with antistaphylococcal penicillin as a primary antibiotic (60/88). The main MSSA clonal complexes identified were CC398 (17/88), CC30 (13/88) and CC5 (13/88). Cefazolin inoculum effect was observed in 18/88 strains, and oxacillin inoculum effect in 13/88. Overall, 15/88 isolates exhibited an inoculum effect on primary antibiotic therapy. Factors independently associated with improved outcomes included cardiac surgery [hazard ratio (HR) 0.34, 95% CI (0.13–0.89)] and source control [HR 0.21, 95% CI (0.03–0.53)]. Neither genetic background, blaZ carriage, nor in vitro inoculum effect to the primary antibiotherapy was associated with Day-90 mortality.

Conclusions

This cohort of MSSA IE did not find any microbiological factors correlated with Day-90 mortality. Clinical features and infection management appear to be the main factors in the prognosis of MSSA IE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenotypeEndocarditis, BacterialStaphylococcal InfectionsStaphylococcus aureusHumansMaleFemaleMiddle AgedProspective StudiesAgedAnti-Bacterial AgentsMicrobial Sensitivity TestsCefazolinAdultRisk FactorsAged, 80 and overOxacillin

Substanzen

Anti-Bacterial AgentsCefazolinOxacillin

Autor:innen und Institutionen

  • Unité de Bactériologie, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.
  • EA 7380 DYNAMIC, Université Paris-Est Créteil, Créteil, France.
  • Unité Transversale de Traitement des Infections, Département de Prévention, Diagnostic et Traitement des Infections, Hôpital Henri Mondor, APHP, Créteil, France.
  • Service de Cardiologie, DMU Médecine, Hôpital Henri Mondor, APHP, Créteil, France.
  • Plateforme de Génomique GenoBioMICS, Hôpital Henri Mondor, APHP, Créteil, France.
  • INSERM U955, Institut Mondor de Recherche Biomédicale, Créteil, France.

ORCID-Profile: Thiziri Tala-Ighil, Guilhem Royer, Vincent Fihman, Pascal Lim, Hervé Jacquier, Paul-Louis Woerther

Zitieren

APA

Tala-Ighil, T., Royer, G., Lepeule, R., Fihman, V., Galy, A., Lim, P., Rodriguez, C., Jacquier, H., & Woerther, P. L. (2025). Clinical features and medical–surgical management overweight the inoculum effect and genotypic characteristics of MSSA in infective endocarditis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf115

Vancouver

Tala-Ighil T, Royer G, Lepeule R, Fihman V, Galy A, Lim P, et al. Clinical features and medical–surgical management overweight the inoculum effect and genotypic characteristics of MSSA in infective endocarditis. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf115

BibTeX
@article{TalaIghil2025,
  author = {Tala-Ighil, Thiziri and Royer, Guilhem and Lepeule, Raphaël and Fihman, Vincent and Galy, Adrien and Lim, Pascal and Rodriguez, Christophe and Jacquier, Hervé and Woerther, Paul-Louis},
  title = {Clinical features and medical–surgical management overweight the inoculum effect and genotypic characteristics of MSSA in infective endocarditis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf115}
}
Kostenlos starten →